VasoRx
About:
VasoRx is developing RNA therapies for diseases of the cardiovascular system & oncology such as atherosclerosis and pulmonary hypertension.
Website: https://vasrx.com/
Top Investors: Good Ventures
Description:
VasoRx is developing RNA therapies for diseases of the cardiovascular VasoRx is leading the translation of technologies discovered at Massachusetts Institute of Technology (M.I.T) and Yale for the delivery of RNAs for the treatment of diseases. With the world’s first approved RNAi therapeutic, the field of RNA medicines is rapidly expanding. VasoRx utilizes novel nanoparticles that are dramatically expanding the opportunities for developing RNA therapies for diseases of the cardiovascular system as well as oncology. system & oncology such as atherosclerosis and pulmonary hypertension.
$7.15M
$1M to $10M
Santa Barbara, California, United States
2018-01-01
Daniel Anderson, Krisztina Zsebo, Michael Simons, Robert Langer
1-10
2020-11-01
Private
© 2025 bioDAO.ai